scholarly journals Launching of a cochlear implant program at the Cracow Otolaryngology Clinic

2019 ◽  
Vol 8 (1) ◽  
pp. 1-5
Author(s):  
Maciej Wiatr ◽  
Kazimierz Niemczyk ◽  
Jacek Składzień ◽  
Agnieszka Wiatr

Introduction: It is estimated that hearing impediment affects approximately 12% of the population. Some forms of hearing disorders can be successfully treated conservatively, while in others surgery plays a key role. Often, therapeutic methods are exhausted and the patient faces the decision about the need for acoustic organ prosthesis. Depending on the causes of anomalies, apparatus for air conduction, bone conduction or cochlear implants are used. A cochlear implant replaces the damaged sensory cells of the inner ear. It constitutes an electronic prosthesis of the acoustic organ, composed of two parts. The internal part (implanted in the inner ear) consists of an implant and electrodes, which conduct electrical signals to the cochlea. The external part consists of a microphone, a speech processor, and a transmitter. Care report: A 70-year-old patient with deep hearing loss in the right ear and deafness of the left ear. During the interview, the patient denied mechanical injuries of the head and neck, acoustic trauma, inflammation or otorrhea. Based on the conducted tests, qualification otolaryngology, audiology, and otoneurology, radiology, surdologopedy and psychology were performed for cochlear implant insertion. The patient was qualified for cochlear implantation in the left ear under general anesthesia. The surgical team was composed of dr hab. Maciej Wiatr, prof. dr hab. Kazimierz Niemczyk, prof. dr hab. Jacek Składzień, MD Agnieszka Wiatr with anesthetic monitoring under the supervision of MD Renata Witkowska. The patient was discharged home on day 7 after surgery in good general and local condition. Simultaneous rehabilitation was started at the Center for Daily Rehabilitation of Hearing and Speech at the Specialist Center of Diagnosis and Rehabilitation for Children and Adolescents with Hearing Disabilities of the Polish Association of the Deaf in Cracow.

Life ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. 301
Author(s):  
Kathrin Malfeld ◽  
Nina Armbrecht ◽  
Holger A. Volk ◽  
Thomas Lenarz ◽  
Verena Scheper

In recent years sensorineural hearing loss was found to affect not exclusively, nor at first, the sensory cells of the inner ear. The sensory cells’ synapses and subsequent neurites are initially damaged. Auditory synaptopathies also play an important role in cochlear implant (CI) care, as they can lead to a loss of physiological hearing in patients with residual hearing. These auditory synaptopathies and in general the cascades of hearing pathologies have been in the focus of research in recent years with the aim to develop more targeted and individually tailored therapeutics. In the current study, a method to examine implanted inner ears of guinea pigs was developed to examine the synapse level. For this purpose, the cochlea is made transparent and scanned with the implant in situ using confocal laser scanning microscopy. Three different preparation methods were compared to enable both an overview image of the cochlea for assessing the CI position and images of the synapses on the same specimen. The best results were achieved by dissection of the bony capsule of the cochlea.


Molecules ◽  
2018 ◽  
Vol 23 (10) ◽  
pp. 2507 ◽  
Author(s):  
Sho Kanzaki

The inner ear contains many types of cell, including sensory hair cells and neurons. If these cells are damaged, they do not regenerate. Inner ear disorders have various etiologies. Some are related to aging or are idiopathic, as in sudden deafness. Others occur due to acoustic trauma, exposure to ototoxic drugs, viral infections, immune responses, or endolymphatic hydrops (Meniere’s disease). For these disorders, inner ear regeneration therapy is expected to be a feasible alternative to cochlear implants for hearing recovery. Recently, the mechanisms underlying inner ear regeneration have been gradually clarified. Inner ear cell progenitors or stem cells have been identified. Factors necessary for regeneration have also been elucidated from the mechanism of hair cell generation. Inducing differentiation of endogenous stem cells or inner ear stem cell transplantation is expected. In this paper, we discuss recent approaches to hair cell proliferation and differentiation for inner ear regeneration. We discuss the future road map for clinical application. The therapies mentioned above require topical administration of transgenes or drug onto progenitors of sensory cells. Developing efficient and safe modes of administration is clinically important. In this regard, we also discuss our development of an inner ear endoscope to facilitate topical administration.


1970 ◽  
Vol 13 (1) ◽  
pp. 37-40
Author(s):  
Gary Thompson ◽  
Marie Denman

Bone-conduction tests were administered to subjects who feigned a hearing loss in the right ear. The tests were conducted under two conditions: With and without occlusion of the non-test ear. It was anticipated that the occlusion effect, a well-known audiological principle, would operate to draw low frequency bone-conducted signals to the occluded side in a predictable manner. Results supported this expectation and are discussed in terms of their clinical implications.


2010 ◽  
Vol 31 (1) ◽  
pp. 134-145 ◽  
Author(s):  
Isaac Alvarez ◽  
Angel de la Torre ◽  
Manuel Sainz ◽  
Cristina Roldán ◽  
Hansjoerg Schoesser ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Daniele Bernardeschi ◽  
Yann Nguyen ◽  
Francesca Yoshie Russo ◽  
Isabelle Mosnier ◽  
Evelyne Ferrary ◽  
...  

Objective. To evaluate the cutaneous and the inner ear tolerance of bioactive glass S53P4 when used in the mastoid and epitympanic obliteration for chronic otitis surgery.Material and Methods. Forty-one cases have been included in this prospective study. Cutaneous tolerance was clinically evaluated 1 week, 1 month, and 3 months after surgery with a physical examination of the retroauricular and external auditory canal (EAC) skin and the presence of otalgia; the inner ear tolerance was assessed by bone-conduction hearing threshold 1 day after surgery and by the presence of vertigo or imbalance.Results. All surgeries but 1 were uneventful: all patients maintained the preoperative bone-conduction hearing threshold except for one case in which the round window membrane was opened during the dissection of the cholesteatoma in the hypotympanum and this led to a dead ear. No dizziness or vertigo was reported. Three months after surgery, healing was achieved in all cases with a healthy painless skin. No cases of revision surgery for removal of the granules occurred in this study.Conclusion. The bioactive glass S53P4 is a well-tolerated biomaterial for primary or revision chronic otitis surgery, as shown by the local skin reaction which lasted less than 3 months and by the absence of labyrinthine complications.


2010 ◽  
Vol 31 (3) ◽  
pp. 512-518 ◽  
Author(s):  
Alexander M. Huber ◽  
Sim Jae Hoon ◽  
Bonabi Sharouz ◽  
Bodmer Daniel ◽  
Eiber Albrecht

1999 ◽  
Vol 8 (2) ◽  
pp. 128-136 ◽  
Author(s):  
John C. Sun ◽  
Margarate W. Skinner ◽  
S. Y. Liu ◽  
T. S. Huang

This study’s purpose was to determine whether or not modifications in speech processor electrical stimulation levels were associated with changes in five Nucleus 22 cochlear implant recipients’ thresholds or maximum acceptable loudness levels (MALs). These modifications in minimum and maximum stimulation levels were made to optimize hearing in everyday life. One threshold and one MAL were obtained on each active electrode during six, weekly test sessions, three before and three after program modification. Only one participant had a significant change in threshold after program modification; this participant and four others had significant changes in MAL. Participants’ threshold variability was the same, but MAL variability was higher than that observed in other studies. Because these participants had no experience making MAL judgments prior to this study, this result suggests that implant recipients should be given sufficient practice in making MAL judgments to provide a stable clinical estimate of the upper boundary of the electrical dynamic range.


Sign in / Sign up

Export Citation Format

Share Document